![Wei Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wei Wang
Director/Miembro de la Junta en MingMed Biotechnology Co., Ltd. .
Perfil
Wei Wang is currently a Member-Supervisory Board at MingMed Biotechnology Co., Ltd.
He obtained an MBA from The University of Hull in 2003.
Cargos activos de Wei Wang
Empresas | Cargo | Inicio |
---|---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Director/Miembro de la Junta | 24/06/2022 |
Formación de Wei Wang.
The University of Hull | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- Wei Wang